Evidence map›Paper›PMID 36358581›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy.

Kamilla Gömöri, Melissa Herwig, Roua Hassoun, Heidi Budde, Nusratul Mostafi, Simin Delalat, Suvasini Modi, Merima Begovic, Tamara Szabados, Judit Pipis and 8 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Kamilla GömöriDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.ORCID 0000-0001-9793-3138
Melissa HerwigDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.ORCID 0000-0003-3245-5504
Roua HassounDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Heidi BuddeDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Nusratul MostafiDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Simin DelalatDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Suvasini ModiDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Merima BegovicDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Tamara SzabadosDepartment of Pharmacology and Pharmacotherapy, University of Szeged, HU-6720 Szeged, Hungary.ORCID 0000-0001-8920-1666
Judit PipisDepartment of Pharmacology and Pharmacotherapy, University of Szeged, HU-6720 Szeged, Hungary.
Nikolett Farkas-MorvayDepartment of Pharmacology and Pharmacotherapy, University of Szeged, HU-6720 Szeged, Hungary.
István LepránDepartment of Pharmacology and Pharmacotherapy, University of Szeged, HU-6720 Szeged, Hungary.
Árpád KovácsDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Andreas MüggeDepartment of Cardiology, St. Josef-Hospital, Ruhr University Bochum, 44801 Bochum, Germany.
Péter FerdinandyPharmahungary Group, HU-6720 Szeged, Hungary.
Anikó GörbeDepartment of Pharmacology and Pharmacotherapy, University of Szeged, HU-6720 Szeged, Hungary.
Péter BencsikDepartment of Pharmacology and Pharmacotherapy, University of Szeged, HU-6720 Szeged, Hungary.ORCID 0000-0003-1936-6232
Nazha HamdaniDepartment of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
St. Josef-Hospital · DEUniversity of Szeged · HUSemmelweis University · HUEötvös Loránd University · HU

Funding

DFG (Deutsche Forschungsgemeinschaft) HA 7512/2-4 and HA 7512/2-1EMBO short-term fellowship 8792Eu-ropean HCEMM HU26307383EU's Horizon 2020 No. 739593Hungarian National Cardiovascular Laboratory RRF-2.3.1-21-2022-00003Hungarian National Scientific Research Fund OTKA-138223, K139237János Bolyai Re-search Fellowship of the Hungarian Academy of Sciences bo_481_21New National Excellence Program UNKP-21-5-SZTE-543NRDI Fund 2019-1.1.1-PIACI-KFI-2019-00367Thematic Excellence Programme 2020-4.1.1.-TKP2020
6 · The paper itself

Abstract

Volume-induced hypertrophy is one of the risk factors for cardiac morbidity and mortality. In addition, mechanical and metabolic dysfunction, aging, and cellular redox balance are also contributing factors to the disease progression. In this study, we used volume overload (VO), which was induced by an aortocaval fistula in 2-month-old male Wistar rats, and sham-operated animals served as control. Functional parameters were measured by transthoracic echocardiography at termination 4- or 8-months after VO. The animals showed hypertrophic remodeling that was accompanied by mechanical dysfunction and increased cardiomyocyte stiffness. These alterations were reversible upon treatment with glutathione. Cardiomyocyte dysfunction was associated with elevated oxidative stress markers with unchanged inflammatory signaling pathways. In addition, we observed altered phosphorylation status of small heat shock proteins 27 and 70 and diminished protease expression caspases 3 compared to the matched control group, indicating an impaired protein quality control system. Such alterations might be attributed to the increased oxidative stress as anticipated from the enhanced titin oxidation, ubiquitination, and the elevation in oxidative stress markers. Our study showed an early pathological response to VO, which manifests in cardiomyocyte mechanical dysfunction and dysregulated signaling pathways associated with enhanced oxidative stress and an impaired protein quality control system.

Indexed as

heat shock proteinshypertrophyoxidative stressprotein quality controlvolume overload

Identifiers

PMID36358581
PMCPMC9686542
OpenAlexW4308772245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.